Digestive System Tumor clinical trials at UCSF

2 in progress, 1 open to eligible people

A digestive system tumor is a growth in the mouth, esophagus, stomach, liver, pancreas, or bowels. UCSF is running trials of radiation for cancers that spread beyond the original organ. Researchers watch tumor size and monitor side effects.

Showing trials for

  • Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

    open to eligible people ages 18 years and up

    This phase II trial studies how well radiation therapy works for the treatment of gastrointestinal cancer that are spreading to other places in the body (metastatic). Radiation therapy uses high energy x-rays to kill cancer cells and shrink tumors. This trial is being done to determine if giving radiation therapy to patients who are being treated with immunotherapy and whose cancers are progressing (getting worse) can slow or stop the growth of their cancers. It may also help researchers determine if giving radiation therapy to one tumor can stimulate the immune system to attack other tumors in the body that are not targeted by the radiation therapy.

    San Francisco, California and other locations

  • TheraSphere With Durvalumab and Tremelimumab for HCC

    Sorry, in progress, not accepting new patients

    The objective of the ROWAN clinical study is to assess the efficacy of local tumor control in HCC patients who receive TheraSphere followed by durvalumab and tremelimumab.

    San Francisco, California and other locations

Our lead scientists for Digestive System Tumor research studies include .

Last updated: